Nirmatrelvir plus ritonavir in patients with underlying rheumatological diseases, in preventing COVID-19 related hospitalization and death
Crossref DOI link: https://doi.org/10.1186/s42358-024-00388-6
Published Online: 2024-07-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Javed, Faiza http://orcid.org/0000-0002-1931-5497
Mangino, Anthony A.
Piranavan, Paramarajan
Text and Data Mining valid from 2024-07-03
Version of Record valid from 2024-07-03
Article History
Received: 21 December 2023
Accepted: 30 May 2024
First Online: 3 July 2024
Declarations
:
: Not applicable.